{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-132565","form_type":"8-K","ticker":"CABA","cik":"0001759138","company_name":"Cabaletta Bio, Inc.","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.416240+00:00","generated_at":"2026-06-16T03:43:48.181576+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Cabaletta to present CABA-201 preclinical data and DSG3-CAART update at ASGCT","bullets":["Oral presentation on CD19 CAR T for SLE by CSO Samik Basu at ASGCT on May 16.","New preclinical data for CABA-201 (CD19 CAR T) shows comparable activity to FMC63 construct.","Updated DSG3-CAART clinical data shows enhanced persistence with IVIG/cyclophosphamide preconditioning.","Poster presentations on May 18 and 19; abstracts published on ASGCT website."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-132565","json":"https://secwatch.observer/filing/0001193125-23-132565.json","markdown":"https://secwatch.observer/filing/0001193125-23-132565.md","text":"https://secwatch.observer/filing/0001193125-23-132565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759138/000119312523132565/0001193125-23-132565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759138/000119312523132565/d134990d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T03:43:48.181576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}